• Who we are
  • What we do
  • Who we serve
  • Resources
Back
  • About Us
  • Leadership
  • Infrastructure
  • Contact
Biologics
  • Cell Line Development
  • Protein Expression & Purification
  • Protein Analytics and Characterization Services
  • Process Development & Characterization
  • GMP Manufacturing
  • Antibody Discovery
  • Molecular Biology
Preclinical Efficacy Testing
  • Fibrosis
  • Oncology
  • Immunology and In Vitro Pharmacology
  • Infectious Diseases
  • Respiratory Diseases
  • Histology and Digital Pathology
  • Biotech
  • Biosimilars
  • Animal Health
  • Government and Academic Research
  • Webinar
  • Technical Content
  • Testimonials
  • News and Events

© 2024 Aragen Bioscience. All rights reserved

Search

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

An optimal upstream process development approach to increase the titers of the monoclonal antibodies (mAbs)

Learn more about our end-
to-end capabilities

✽
✽
✽
✽
✽
✽
✽

© 2024 Aragen Bioscience. All rights reserved

Quick Links
  • About Us
  • Our Services
  • News & Events
Utilities
  • Term Of Use
  • Privacy Policy
  • Policy Statement
Aragen Bioscience

380 Woodview Avenue
Morgan Hill, CA 95037, USA

T: +1 408 549 9200
F: +1 408 779 1711

Biologics Manufacturing Facility

Plot No. 284 Part A
Bommasandra Jigani Link Road, Jigani
Bengaluru 562 106, India

T: +91 80 6814 7676

BACK TO TOP